Acrylic polymers for colonspecific drug delivery

S.T.P. Pharma Sciences

Volumn 7, Issue 6, 1997, Pages 546-554

  David, A ^a,b   Yagen, B ^a   Sintov, A ^a   Rubinstein, A ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acrylic polymers; Colonie delivery cellobios ; Ethylene glycol dimethacrylate; Hydroxyethyl methacrylate; Methacrylic acid copolymer

Indexed keywords

2 HYDROXYETHYL METHACRYLATE; CARBOHYDRATE DERIVATIVE; CELLOBIOSE; INDOMETACIN; POLYACRYLIC ACID; POLYMETHACRYLIC ACID;

ARTICLE; COLON; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG SPECIFICITY; DRUG STABILITY; ENTERIC COATED TABLET; HYDROGEL; LARGE INTESTINE; SUSTAINED DRUG RELEASE;

EID: 0031544302     PISSN: 11571489     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. RUBINSTEIN A. and FRIEND D.R. Specific delivery to the gastrointestinal tract. In : Polymer SiteSpecific Pharmacotherapy, A.J, Domb Ed., John Wiley & Sons, Sussex, 1994, pp. 267313.
2. RUSSELL T.L., BERARDI R.R., BARNETT J.L., DERMENTZOGLOU L.C., JARVENPAA K.M., SCHMALTZ S.P. and DRESSMAN J.B. Upper gastrointestinal pH in seventynine healthy, elderly, North American men and women, Pharm Res., 10,187196,1993.
3. KERSS S., ALLEN A. and GARNER A. A simple method for measuring thickness of mucus gel layer adherent to rat, frog and human gastric mucosa : influence of feeding, prostaglandin, Wacetylcysteine and other agents. Clin. Sei., 63, 187195, 1982.
4. KELLOW J.E., BORODY T.J., PHILLIPS S.F., TUCKER R.L. and HADDAD A.C. Human interdigestive motility : variations in patterns from oesophagus to colon Gastroenterology, 91, 386395, 1986.
5. ASTHANA O.P., WOODCOCK B.G., WENCHEL M., FROMMING K.H., SCHWABE L. and REITBROCK N. Verapamil disposition and effect on PQintervals after buccal, oral and intravenous administration. Arzn. Forsch. 34, 498502, 1984.
6. HARRIS D. and ROBINSON J.R. Drug delivery via the mucous membranes of the oral cavity J. Pharm. Sei., 81,110, 1992.
7. MAZER N., AB1SCH E., GFELLER J.C., LAPLANCHE R., BAUERFEIND P., CUCALAM., LUKACHICH M. and BLUM A. Intragastric behavior and absorption kinetics of a normal and floating modifiedrelease capsule of isradipine under fasted and fed conditions. J. Pharm. Sei., 77, 647657, 1988.
8. PARK K. and ROBINSON J.R. Bioadhesive polymers as platforms for oralcontrolled drug delivery : method to study bioadhesion. Int. J. Pharm., 19, 107127,1984.
9. PEPPAS N.A. and BURI P. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Controlled Release, 2, 257275, 1985.
10. SMART J.D., KELLAWAY I.W, and WORTHINGTON H.E.C. An in vitro investigation of mucosa adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol., 36,295299, 1984.
11. LUESSEN H.L., LEHR C.M., RENTEL C.O., NOACH A.B.J., DE BOER A.G., VERHOEF J.C. and JUNGINGER H.E. Bioadhesive polymers forthe peroral delivery of peptide drugs. J. Controlled Release, 29, 329338, 1994.
12. KORELITZ B.I. Where do we stand on drug treatment for ulcerative colitis? Anal. Int. Med., 116, 692694, 1992.
13. HANAUER S. Medical therapy of ulcerative colitis. Lancet, 342,412417, 1993.
14. PASSARETTI S., SORGHI M., COLOMBO E., MAZZOTTI G., TITTOBELLO A. and GUSLANDI M. Motor effects of locally administered pinaverium bromide in the sigmoid tract of patients with irritable bowel syndrome. Int. J. Clin. Pharmacol. Ther. Tox.,27, 4750, 1989.
15. NOLEN H.W. and FRIEND D.R. MentholtDglucuronide : a potential prod rug for treatment of the irritable bowel syndrome. Pharm. Res., 11, 17071711, 1994.
16. KOHEN R., KAKUNDA A. and RUBINSTEIN A. The role of cationized catalase and cationized glucose oxidase in mucosal oxidative damage induced in the rat jejunum. J. Biol. Chem., 267,2134921354, 1992.
17. RUBINSTEIN A., KAKUNDA A. and KOHEN R. Protection of the rat jejunal mucosa against oxidative injury by cationized super oxide dismutase. J. Pharm. Sei., 82, 12851287,1993.
18. HARRIS M.L., SCHILLER H J., REILLY P.M., DONOWITZ M., GRISHAM M.B. and BULKLEY G.B. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease : cause, consequence or epiphenomenon? Pharm. Ther., 53, 375408, 1992.
19. VAN DER VLIET A. and BAST A. Role of reactive oxygen species in intestinal diseases. Free Rad. Biol. Med., 12, 499513, 1992.
20. BABBS C.F. Oxygen radicals in ulcerative colitis. Free Rad. Biol. Med., 13, 169181, 1992.
21. RUBINSTEIN A. Approaches and opportunities in colonspecific drug delivery. Crit. Rev. Ther. Drug Carr. Sys.,12, 101149, 1995.
22. GIBSON S.T., MacFARLANE C., HAY S. and MacFARLANE G.T. Significance of microflora in proteolysis in the colon. Appl. Environ. Microbiol., 55, 679683, 1989.
23. BAI J.P.F. Distribution of brushborder membrane peptides along the rat intestine. Pharm. Res., 11, 897900, 1994.
24. SAFFRAN M., KUMAR G.S., SAVARIAR C., BURNHAM J.C., WILLIAMS F. and NECKERS D.C. A new approach to the oral administration of insulin and other peptide drugs. Science, 233, 10811084, 1986.
25. KRAELING M.E.K. and RITSCHEL W.A. Development of colonie release capsule dosage form and the absorption of insulin. Meth. Find. Exp. Clin Pharmacol., 14, 199209,1992.
26. BAI J.P.F. Colonie delivery of peptide and protein drugs : consideration of intracellular proteolytic enzymes. S.T.P. Pharma Sei., 5, 3035, 1995.
27. KOPECKOVA P., IKESUE K. and KOPECEK J. Cleavage of oligopeptide pnitroanilides attached to A/(2hydroxypropyl)methacrylamide copolymers by guinea pig intestinal enzymes. Makromol. Chem., 193, 26052619,1992.
28. IKESUE K., KOPECKOVA P. and KOPECEK J. Degradation of proteins by guinea pig intestinal enzymes. Int. J. Pharm., 95, 171,1993.
29. MURANISHI S. Absorption enhancers. Grit. Rev. Ther. Drug Carriers Sys, 7, 133, 1990.
30. TOMITA M., SHIGA M., HAYASHI M. and AWAZU S. Enhancement of colonie drug absorption by the paracellular permeation route. Pharm. Res., 5, 341346,1988.
31. KIM J.S., OBERLE R.L, KRUMMEL D.A., DRESSMAN J.B. and FLEISHER D. Absorption of ACE inhibitors from small intestine and colon. J. Pharm. Sei., 83, 13501356, 1994.
32. SINTOV A., SIMBERG M. and RUBINSTEIN A. Absorption enhancement of captopril in the rat colon as a putative method for captopril delivery by extended release formulations. Int. J. Pharm., 143, 101106, 1996.
33. AGYILIRAH G,A. and BANKER G.S. Polymers for enteric coating applications. In : Polymers for Controlled Drug Delivery, P.J. Tarch Ed., CRC Press, Boca Raton, 1991, pp. 3966.
34. RASMUSSEN S.N., RONDESEN S., HVIDBERG E.F., HONORE HANSEN S., BINDER V., HALSKOV S. and FLACHS H. 5aminosalicylic acid in a slowrelease preparation : bioavailability, plasma level, and excretion in humans. Gastroenterology, 83, 10621070,1982.
35. KLOTZ U., MAIER K.E., FISCHER C. and BAUER K.H. A new slowrelease form of 5aminosalicylic acid for the oral treatment of inflammatory bowel disease. Biopharmaceutic and clinical pharmacokinetic characteristics. Arzneimittelforschung, 35, 636639, 1985.
36. FORD G.A., OLIVER P.S., SHEPHERD N.A. and WILKINSON S.P. A Eudragitcoated prednisolone preparation for ulcerative colitis : pharmacokinetics and preliminary therapeutic use. Aliment. Pharmacol. Therap., 6, 3140, 1993.
37. EVANS D.F.,PYEG.,BRAMLEYR.,CLARKA.G.,DYSONT.J. and HARDCASTLE J.D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut, 29, 10351041,1988.
38. ASHFORD M, FELL J.T., ATTWOOD D. and WOODHEAD P.J. An in vitro investigation into the suitability of pHdependent polymers for colonie targeting. Int. J. Pharm., 91, 241245, 1993.
39. ASHFORD M., FELL J.T., ATTWOOD D., SHARMA H. and WOODHEAD P.J. An in vivo investigation into the suitability of pHdependent polymers for colonie targeting Int. J. Pharm., 95, 193199,1993.
40. CHUNG K.T., STEVENS S.E. Jr. and CERNIGLIA C.E. The reduction of azo dyes by the intestinal microflora. Crit. Rev. Microbiol., 18, 175190, 1992.
41. BROWN J.P. Reduction of polymeric azo and nitro dyes by intestinal bacteria. Appl. Environ. Microbiol., 41, 12831286, 1981.
42. SAFFRAN M., KUMAR O.S., NECKERS D.C., PENA J., JONES R.H. and FIELD J.B. Biodegradable azopolymer coating for oral delivery of peptide drugs. Biochem. Soc. Trans.,18, 752754, 1990.
43. BRONDSTED H. AND KOPECEK J. Hydrogels for sitespecific drug delivery to the colon : in vitro and in vivo degradation. Pharm. Res., 12, 15401545, 1992.
44. KOPECEK J., KOPECKOVA P., BRONDSTED H., RATHI R., RIHOVA R., YEH P.Y. and IKESUE K. Polymers for colonspecific drug delivery. J. Controlled Release, 19, 121130, 1992.
45. RATHI R., KOPECKOVA P., RIHOVA B. and KOPECEK J. N(2hydroxypropyl)methacrylamide copolymers containing pendant saccharide moieties : synthesis and bioadhesives properties. J. Polymer Sei., 29, 18951902, 1991,
46. VAN DEN MOOTER G., SAMYN C. and KINGET R. Azo polymers for colonspecific drug delivery. Int. J. Pharm., 87, 3746, 1992.
47. VAN DEN MOOTER G., SAMYN C. and KINGET R. Azo polymers for colonspecific drug delivery. II : Influence of the type of azo polymer on thedegradation by intestinal microflora. Int. J. Pharm., 97, 133139, 1993.
48. SAMYN C., KALALA W., VAN DEN MOOTER G. and KINGET R. Synthesis and in vitro biodégradation of poly(etherester) azo polymers designed for colon targeting, Int. J. Pharm., 121, 211-216, 1995.
49. LEH'MANN' K.Ö.R. and DREHER K.D. Methacrylategalastamannan coating for colonspecific drug delivery. Proceed; Intern. Symp. Control. Ret. Bioact. Mater., 18, 331338,1991.
50. SIEFKE V., WECKENMANN H. P. and BAUER K. H. cyolodextrin rnaWix films for colonspecific drug delivery. Proc. Int.;Symp. Control. Release Bioact. Mater., 20,182183,1993.
51. 9INTOV A., ANKOL B., LEVY DP. and RUBINSTEIN A. Enzymatic cleavage of disaccharide side groups in Insoluble synthetic polymers : a new method for specific delivery of drugs to the colon. Biomaterials, 14, 483490,1993.
52. CHRISTIANSEN'BRAMS I., MELDAL M. and BOCK K. Synthesis of the 1 aminoalditols derived from oelfobiose, lactose and maltose, a comprehensive NMR study of some alditois and aminoaldltols. J. Cartaohyd. Chern., 11, 813835,1992,
53. FERRUTI P., BETTELU A. and FERE A. High polymers of acrylic and methacrylic filers of Nhydfoxysuoelnimide as polyacrylamlde and polymflsiiacrylarnid) precursors, 'Polymer, 13,462464, 1972.